SURG vs ENSC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 30, 2026

SURG

51.9
AI Score
VS
SURG Wins

ENSC

39.2
AI Score

Investment Advisor Scores

SURG

52score
Recommendation
HOLD

ENSC

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric SURG ENSC Winner
Forward P/E 3.3546 0.9496 ENSC
PEG Ratio 0.5333 0 Tie
Revenue Growth 40.7% -15.1% SURG
Earnings Growth -77.7% 0.0% ENSC
Tradestie Score 51.9/100 39.2/100 SURG
Profit Margin -47.9% -280.5% SURG
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL SURG

Relative Price Performance (Last 90 Days)

SURG 1M: -23.4% · 3M: -72.0% ENSC 1M: +55.2% · 3M: +40.2%

Current Technical Phase

SURG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -26.6%), weak momentum, RSI 34

RSI (14): 34.4 · Price: $0.17

ENSC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (18.0% over 20 days), RSI 54

RSI (14): 54.3 · Price: $0.39

Fundamentals Snapshot

Metric SURG ENSC
Market Cap
Forward P/E 3.3 -7.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.4% -0.2%
Gross Margin -0.2% -1.3%
Operating Margin 0.2% -2.2%
EPS -1.49 -2.54
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SURG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.